Locations
United States · Burlington, MA, USA
industry
Health
Size
11-50 employees
Stage
Seed
founded in
2020
SiPhox was founded by Diedrik Vermeulen and Michael Dubrovsky one month BC (before Covid) in 2020. SiPhox’s mission is to build a next-generation biosensing platform that provides the power of several large laboratory instruments in a handheld device that accepts disposable cartridges. Each cartridge can multiplex many biomarkers on a single $0.50 silicon photonic chip and provides highly sensitive readout of immunoassays and RNA/DNA. The SiPhox team has extensive experience translating cutting-edge optical chip technology into mass produced products used all over the world, and is bringing the same proven approach to the next frontier for integrated photonics: biology.
Something looks off?